<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05047068</url>
  </required_header>
  <id_info>
    <org_study_id>OCSHEART-01-ClinPAS</org_study_id>
    <nct_id>NCT05047068</nct_id>
  </id_info>
  <brief_title>OCS Heart Perfusion Post-Approval Registry</brief_title>
  <official_title>OCS Heart Perfusion (OHP) Post-Approval Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TransMedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TransMedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this post-approval registry is to provide additional real-world evidence of&#xD;
      the performance of the OCS Heart System to preserve DBD donor hearts.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multi-center, observational post-approval registry to compare patient and graft survival of&#xD;
      adult primary heart transplant recipients receiving DBD donor hearts perfused and assessed on&#xD;
      the OCS Heart System compared to adult recipients of DBD donor hearts preserved using&#xD;
      ischemic cold storage hearts (Control) at the same Registry centers over the same time&#xD;
      period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 2029</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Patient Survival</measure>
    <time_frame>One year</time_frame>
    <description>Patient survival at one-year post-heart transplant</description>
  </primary_outcome>
  <other_outcome>
    <measure>Safety Endpoint</measure>
    <time_frame>6 months</time_frame>
    <description>Heart graft survival at 6 months post-heart transplant</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart and Graft Survival</measure>
    <time_frame>5 years post transplant</time_frame>
    <description>For both OCS Heart PAP and Control Recipients:&#xD;
K-M Patient survival at 1, 2, 3, 4 and 5 years post-transplant&#xD;
K-M Graft survival at 6mo, 1, 2, 3, 4 and 5 years post-transplant</description>
  </other_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Transplant</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OCS Heart</intervention_name>
    <description>Multi-center, observational post-approval registry to compare patient and graft survival of adult primary heart transplant recipients receiving DBD donor hearts perfused and assessed on the OCS Heart System compared to adult recipients of DBD donor hearts preserved using ischemic cold storage hearts (Control) at the same Registry centers over the same time period.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be adult primary heart transplant potential recipients on the waiting&#xD;
        list for heart transplantation at the participating Registry centers.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult primary heart transplant recipients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concurrent (multi-organ transplant) or previous solid organ or bone marrow transplant;&#xD;
             or&#xD;
&#xD;
          -  On renal dialysis at time of transplant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Raicca Haqqi</last_name>
    <phone>9788090620</phone>
    <email>rhaqqi@transmedics.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kausar Qidwai</last_name>
    <phone>9785520984</phone>
    <email>kqidwai@transmedics.com</email>
  </overall_contact_backup>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 8, 2021</study_first_submitted>
  <study_first_submitted_qc>September 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

